Tag results:
circulating tumor cells
Intestinal Cell News
Transcriptomic Profiling of Single Circulating Tumor Cells Provides Insight into Human Metastatic Gastric Cancer
[Communications Biology] Researchers utilized an antigen-independent strategy for circulating tumor cell (CTC) isolation from metastatic gastric cancer patients involving a size-dependent recovery of CTCs and a single cell isolation technique.
Prostate Cell News
Alternative Splicing of NF-YA Promotes Prostate Cancer Aggressiveness and Represents a New Molecular Marker for Clinical Stratification of Patients
[Journal of Experimental & Clinical Cancer Research] Researchers indicated that the modulation of NF-YA isoforms affected prostate pathophysiological processes and contributed to a cancer-relevant phenotype, in vitro and in vivo.
Human Immunology News
PD-L1 Expression on Circulating Tumor Cells and Platelets in Patients with Metastatic Breast Cancer
[PLoS One] Whole blood was collected at serial timepoints from metastatic breast cancer patients and healthy donors for circulating tumor cell and platelet PD-L1 analysis with a phycoerythrin-labeled anti-human PD-L1 monoclonal antibody using the CellSearch® assay.
Mammary Cell News
The Role of Membrane Mucin MUC4 in Breast Cancer Metastasis
[Endocrine-Related Cancer] Investigators discuss the diverse roles of MUC4 in tumor progression and metastasis, and propose that intervening in MUC4 intercellular interactions with binding partners on blood-borne aggregating cells could potentially thwart breast cancer metastatic efficiency.
Extracellular Matrix News
Platelet-Mediated Tumor Metastasis Mechanism and the Role of Cell Adhesion Molecules
[Critical Reviews in Oncology/Hematology] Investigators introduce the mechanism of platelet-related tumor metastasis and particularly focus on the role of cell adhesion molecules in it.
Mammary Cell News
Molecular Testing in Breast Cancer: Current Status and Future Directions
[Journal of Molecular Diagnostics] The authors provide an overview of currently available molecular assays and testing modalities that have prognostic, predictive, and therapeutic value. These include multi-gene assays for invasive breast cancer and ductal carcinoma in situ, and companion tests to detect PIK3CA mutations and NTRK fusions.